---
title: "First Bellwether Trial Today Against Reckitt Benckiser’s Mead Johnson in NEC Baby Formula MDL Led by Levin Papantonio"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296097863.md"
description: "In Pensacola, Florida, a Reckitt Benckiser company, Mead Johnson, is undergoing the initial bellwether trial in a multidistrict litigation (MDL) at the US District Court for the Northern District of Illinois. The case, Inman v. Mead Johnson & Company, LLC, et al., involves their infant formula Enfamil allegedly associated with necrotizing enterocolitis (NEC) in a premature baby. This is the first lawsuit against Mead Johnson in the MDL to advance to trial. NEC is a serious intestinal condition that may …"
datetime: "2026-08-17T11:06:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296097863.md)
  - [en](https://longbridge.com/en/news/296097863.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296097863.md)
generator: "portal-rs"
---

# First Bellwether Trial Today Against Reckitt Benckiser’s Mead Johnson in NEC Baby Formula MDL Led by Levin Papantonio

In Pensacola, Florida, a Reckitt Benckiser company, Mead Johnson, is undergoing the initial bellwether trial in a multidistrict litigation (MDL) at the US District Court for the Northern District of Illinois. The case, Inman v. Mead Johnson & Company, LLC, et al., involves their infant formula Enfamil allegedly associated with necrotizing enterocolitis (NEC) in a premature baby. This is the first lawsuit against Mead Johnson in the MDL to advance to trial. NEC is a serious intestinal condition that may …

### Related Stocks

- [RKT.UK](https://longbridge.com/en/quote/RKT.UK.md)
- [RBGLY.US](https://longbridge.com/en/quote/RBGLY.US.md)
- [RBGLD.US](https://longbridge.com/en/quote/RBGLD.US.md)

## Related News & Research

- [Buy Rating Reaffirmed on Litigation Progress, Price Target Maintained at $5900](https://longbridge.com/en/news/296601286.md)
- [Reckitt unit Mead Johnson draws USD 400.42 million tenders for 2044 notes buyback](https://longbridge.com/en/news/295912622.md)
- [Abbott settles appeal over $495 million infant formula verdict](https://longbridge.com/en/news/296386129.md)
- [Abbott agrees to $670 million settlement of infant formula cases](https://longbridge.com/en/news/296534956.md)
- [16:48 ETGI MAP Test Launches Cyclospora Guidance Service for Customers With a Detected Test Result](https://longbridge.com/en/news/296535077.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**